Genetic approach for intracerebroventricular delivery

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Direct peptide administration into brain ventricles is common but has limitations.
• Intravenous administration is restricted by the blood-brain barrier.
• Current intracerebroventricular delivery methods have technical drawbacks.

Purpose of the Study:

• To develop a novel genetic approach for delivering secreted peptides/proteins into the cerebrospinal fluid (CSF).
• To establish an inducible and reversible gene delivery system.
• To overcome limitations of existing intracerebroventricular delivery methods.

Main Methods:

• Utilized a lentiviral-based system.
• Employed a choroid plexus-specific promoter for targeted gene expression.
• Demonstrated functionality by overexpressing corticotropin-releasing factor and gonadotropin-releasing hormone.

Main Results:

• Successfully delivered gene products into the CSF.
• Inducible and reversible delivery of neuropeptides was achieved.
• Overexpression of corticotropin-releasing factor modulated anxiety-like behavior.
• Overexpression of gonadotropin-releasing hormone affected the estrus cycle.

Conclusions:

• The choroid plexus-specific lentiviral system provides effective and adaptable intracerebroventricular delivery.
• This genetic approach offers a reliable research tool for studying neuropeptide function.
• The system enables precise control over gene product delivery into the CSF.